• 차량이 Juvisy-sur-Orge를 주행하던 중 도로를 이탈하여 강으로 추락함
• 수습 운전사가 몰던 버스가 주차된 차량과 충돌한 후 Paris 인근 Seine 강으로 추락했으며 4명이 구조됨
• 검찰은 해당 버스가 프랑스 수도 남동쪽 Juvisy-sur-Orge 마을을 지나던 중 도로를 벗어나 Seine 강으로 추락했다고 밝힘. Continue reading...
Marine Conservation Society warns that fish numbers have reached dangerous point of declineConsumers should “completely avoid” buying UK-caught cod, the Marine Conservation Society (MCS) has said, as it warned that populations have reached a dangerous point of decline despite zero-catch recommendations.The MCS, an environmental charity, publishes a Good Fish Guide to help consumers and businesses make sustainable seafood choices. Continue reading...
• Sysco shares plunged 12% following the announcement of a $29 billion acquisition of Jetro Restaurant Depot, including debt, in a major foodservice industry deal.
• The deal aims to expand Sysco's market reach but sparked investor concerns over the high cost and integration risks amid volatile markets.
• This merger highlights consolidation trends in the restaurant supply sector, potentially impacting competitors and pricing dynamics.
• Super Micro Computer shares plunged 28.2% on Friday after US authorities accused a senior executive and two affiliates of conspiring to smuggle advanced Nvidia-based servers to China.
• The alleged scheme targeted the export of high-performance computing equipment to China, triggering immediate sharp market reaction and significant shareholder losses.
• The charges represent a significant escalation in enforcement actions against technology companies and executives involved in alleged unauthorized export of advanced semiconductor technology.
Biotech firm Immutep Ltd. crashed more than 80% on March 13, 2026, becoming one of the biggest decliners amid a mixed US market session pressured by geopolitical fears. The plunge contrasted with gains in AI leaders like Intel (+1.7%), Tesla (steady at $395), and Nokia (+1.4%), highlighting sector rotation. This extreme volatility amplifies risks in biotech amid elevated VIX at 26.49 and weekly index losses. Investors may monitor clinical trial updates or funding news for rebound potential.